In the treatment of cerebrospinal fever by antimeningococcus serum the polyvalency of the serum has been considered of the utmost importance. Yet the potency of the polyvalent serum against the individual strain may be sacrificed by immunizing with a large number of strains. The technical difficulties of developing such a serum make its production onerous, while the methods of testing its therapeutic potency are also burdensome and far from satisfactory. Furthermore, in New York State the regulations for the production and standardization of antimeningococcus serum for sale require immunization with and tests against only four representative strains. Manufacturers then might not use more than the four strains required and it is important to determine what effect this procedure would have on the polyvalency of the serum.
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Although the agglutination test is not a satisfactory method of determining therapeutic potency, it is the only one that suggests the degree of polyvalency. The practical value of complement fixation or of measuring the bacteriotropin content has not been demonstrated, and there is no satisfactory protection test.
In this study one horse was immunized with four strains, another with six, and the serums obtained from these horses were compared with the serum obtained from a horse which had been immunized with the regular stock meningococcus cultures--60 strains in all, including the six which were used in the immunization of the horses under investigation. The serum from the horse immunized with the large number of cultures was representative of the classical method, since it had been found to compare favorably with serum produced by The Rockefeller Institute and the Research Laboratory of the Department of Health of the City of New York.
The problem of selecting representative strains was obviously difficult on account of the obstacles encountered in the classification of the meningococci which have been obtained from cases of cerebrospinal meningitis, from carriers , and from healthy persons. The four representative or standard strains selected included one regular strain, one parameningococcus, and two intermediate strains. One horse was immunized with these four cultures; the other horse was immunized with two cultures of each of the three main groups. These strains represented the groups recognized in the classifications of Dopter, I Gordon, 2 Flexner, 3 and others. When only four or six representative strains were used the horse received at each dose an equal quantity of each strain. The dose was increased and adjusted to give rise to approximately the same degree of reaction that was obtained in the immunization with a large number of strains.
Method.
The method of preparing the cultures and immunizing the horses with suspensions of them was similar whether 4, 6, or 60 strains were used for immunization. The cultures were grown on serum dextrose agar slants for 17 to 19 hours at 37°C. and were suspended in 0.85 per cent salt solution. The inoculations were made intravenously 1Dopter, C., ]~tude de quelques germes isol~s du rhino-pharynx, voisins du m6ningocoque (param~ningocoques), Compt. rend. Soc. biol., 1909, lxvii, 74. Gordon, M. H., Bacteriological studies in the pathology and preventive control of cerebro-spinal fever among the forces during 1915 and 1916. II.--The definition of the meningococcus, Med. Research Com., Nat. Health Insurance, Special Rep. Series, No. 3, 1917, 10. 3 Flexner, S., Mode of infection, means of prevention and specific treatment of epidemic meningitis, J. Am. Med. Assn., 1917, lxix, 639. without delay. At the beginning of immunization the first dose was a fraction of a single culture. When a large number of strains was used new strains were added as fast as possible, until twenty were injected daily. Two inoculations were made on each day, 1 hour apart, with ten cultures for each inoculation. This was done to decrease the severity of the reaction. The doses were given on 3 successive days followed by a week of rest, after which another series was begun. The cultures and the method of injection were chosen so that the whole series of stock cultures was injected as often as possible. The increase of dosage was dependent upon the temperature reaction after inoculation, the aim being to secure a rise in temperature to 104 ° or 105°F. 5 hours after inoculation, followed by a fall to normal the next morning.
Trial or complete bleedings were made on the 6th day after every other series of injections. The immunization of the two horses with the four and six representative strains was begun in May~ 1918, and was continued for a period of more than 1 year. The largest dose was a total of 60 cc. of suspension, representing the growth from ten slants of culture. The horses were allowed to rest for 2 months, during August and September, 1918. The potency of the serum was tested according to the standard methods described in a previous paper. 4
Cultures were grown at 37°C. for 18 hours on serum dextrose agar and then suspended in 0.85 per cent salt solution and diluted to a density equal to that of barium sulfate StKndard No. 3, or approximately 2,000 million cocci per cc. In all the tests saline solution, normal horse serum, and type serum controls were used, as well as the standard antimeningococcus serum adopted by this laboratory. Although the standard serum has been used during a period of 2 years, it has shown practically no deterioration in agglutination titer.
According to these standard methods the agglutination titer was determined by the maximum dilution in which definite but not necessarily complete agglutination occurred. Reading the limit of definite Wadsworth, A. B., Kirkbride, M. B., and Gilbert, R., The standardization of antimeningococcus and antipneumococcus serums, Arch. Int. Med., 1919, xxiii, 269. agglutination, rather than of complete agglutination, has been found to be more accurate and practical. Complete agglutination occurs in a much lower dilution, and if a sufficient number of dilutions of serum are used to grade the degree of reaction accurately, different workers may experience difficulty in reading the complete agglutination. Furthermore, the ability of certain cultures to be agglutinated completely, and that of certain serums to agglutinate, vary. Finally, the percentage of discrepancy between the readings of different workers when the upper limits of agglutination are read and high dilutions are made of the serum is not great, especially if the dilutions which are doubtful are always considered negative, and only the highest dilution which shows definite agglutination is read.
RESULTS.
In Tables I and II are recorded agglutination tests on the serums of the two horses during immunization with four and six strains respectively in comparison with the serum of a horse immunized with 60 strains during a period of 18 months (Table III) . The tests were made with the six cultures used in the immunization of the horse mentioned above. The rise in agglutination titer is very rapid during the first few weeks of immunization. Then it is slower until a constantly high titer has been reached, which, however, varies at times quite markedly, doubtless on account of a dose that was too large or too small. The potency as indicated by the agglutination titer with homologous strainswas increased three-to tenfold by limiting the number of strains used in immunization.
Agglutination tests have been made with the serums of horses immunized with 4, 6, and 60 strains of meningococci against 77 homologous and heterologous cultures, including also some strains recently isolated from cases, and others reputed to belong, because of their serological reactions, to the fourth group of Gordon, typical strains of which are not commonly found in this country. From Tables IV and V it is evident that many of the heterologous type cultures were agglutinated to an even higher degree than the homologous cultures. Practically all the twelve unclassified cultures which were used in the immunization of the 60 strain horse, and also the twelve additional cultures, none of which was used in the immuni- The serums obtained from horses immunized with four and with six representative strains as compared with the serum of a horse immunized with 60 stock meningococcus cultures thus possessed a higher agglutination titer. This was marked when the serum was tested against the homologous strains; but a high titer was also found when the serums were tested against all the heterologous strains. Evidently, by the use of too large a number of strains the potency of the serum, as judged from the agglutination titer, is sacrificed. The titer of a polyvalent serum obtained by immunization with 60 strains for 18 months approximated dilutions of 1:700, 1:800, 1:I,000, 1:1,100, 1:900, and 1:1,100 respectively with six representative strains of the different types of meningococci, whereas the horse immunized with these six strains possessed an agglutination titer of 1:4,000, 1:6,000, 1:6,000, 1:12,000, 1:6,000, and 1:12,000 respectively. The horse immunized with only" four of the strains possessed an agglutination titer of I : 4,000, 1 : 4,000, I: 6,000, i: 12,000, I: 4,000, and I: 8,000 respectively, the first and last reactions being heterologous and the others homologous; that is, tests with the cultures used in immunization of the horse. There is thus marked variation in the titer obtained with the different strains, largely owing to the antigenic properties or agglutinability, of the cultures, The titer apparently fluctuated to tome extent while the horses were in a high Since with a small number of strains, such as would meet the minimum requirements of the standards of potency for the manufacture of antimeningococcus serum in New York State, the agglutination titer may be greatly increased, as compared with previous methods in which a large number of strains was used, the minimum standards of potency should be correspondingly increased. Furthermore, the minimum standards of potency, as determined by the agglutination titer, must be adjusted for each standard culture. Until we have had more experience with the variations in titer of serums from a larger number of horses, it is, of course, difficult to determine practically how much to adjust the standard above or below the minimum agglutination titer obtained during the height of immunization in this investigation.
CONCLUSIONS.
The potency of a polyvalent anfimeningococcus serum, as tested by its agglutination titer, was sacrificed by immunization with a large number of strains of the meningococcus. By immunization with a limited number of representative strains, four or six, carefully selected on account of their antigenic and agglutination properties, the potency was increased three-to tenfold without sacrificing the polyvalency; that is, as tested with at least 70 heterologous strains of the meningococcus.
The agglutination titer, unfortunately, is not an entirely satisfactory criterion of therapeutic potency, but it is the only practical method available that determines also the polyvalent action of antimeningococcus serum.
